OrthoPediatrics Corp.’s (NASDAQ:KIDS) quiet period will expire on Tuesday, November 21st. OrthoPediatrics Corp. had issued 4,000,000 shares in its initial public offering on October 12th. The total size of the offering was $52,000,000 based on an initial share price of $13.00. During the company’s quiet period, underwriters and any insiders involved in the IPO are prevented from issuing any research reports or earnings estimates for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Several equities research analysts have recently issued reports on the company. Piper Jaffray Companies assumed coverage on OrthoPediatrics Corp. in a report on Monday, November 6th. They set an “overweight” rating and a $24.00 price target for the company. William Blair assumed coverage on OrthoPediatrics Corp. in a report on Monday, November 6th. They set an “outperform” rating for the company. BTIG Research started coverage on OrthoPediatrics Corp. in a report on Monday, November 6th. They set a “buy” rating and a $24.00 price target for the company. Finally, Stifel Nicolaus started coverage on OrthoPediatrics Corp. in a research note on Monday, November 6th. They issued a “buy” rating and a $23.00 price objective on the stock.

COPYRIGHT VIOLATION NOTICE: “OrthoPediatrics Corp.’s Quiet Period Set To Expire on November 21st (NASDAQ:KIDS)” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another publication, it was illegally copied and reposted in violation of U.S. and international copyright & trademark laws. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/11/14/orthopediatrics-corp-s-quiet-period-set-to-expire-on-november-21st-nasdaqkids.html.

OrthoPediatrics Corp. (NASDAQ KIDS) opened at $19.75 on Tuesday. OrthoPediatrics Corp. has a one year low of $17.03 and a one year high of $23.00.

In other OrthoPediatrics Corp. news, Director Harold Ruf purchased 11,500 shares of the company’s stock in a transaction on Monday, October 16th. The shares were bought at an average cost of $13.00 per share, with a total value of $149,500.00. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

OrthoPediatrics Corp. Company Profile

OrthoPediatrics Corp. is a United States-based medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.

Receive News & Stock Ratings for OrthoPediatrics Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OrthoPediatrics Corp. and related stocks with our FREE daily email newsletter.